These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9016842)

  • 1. Effect of corticotropin releasing factor (CRF) injected into the median eminence on LH secretion in male rats.
    Frias J; Puertas A; Ruiz E; Ortega E
    Neurochem Res; 1997 Feb; 22(2):171-4. PubMed ID: 9016842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of corticotropin releasing factor injected into the median eminence on growth hormone secretion in male rats.
    Frias J; Ruiz E; Ortega E
    Neurochem Res; 1999 Jun; 24(6):715-8. PubMed ID: 10447453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of corticotropin releasing factor (CRF) in the median eminence on gonadotropins in ovariectomized rats with or without steroid priming: dose-response study.
    Ortega E; Ruiz E; Rodriguez E; Frias J
    Neurochem Res; 1994 Oct; 19(10):1225-30. PubMed ID: 7891837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CRF injected into the median eminence on GH secretion in female rats under different steroid status.
    Puertas A; Frias J; Ruiz E; Ortega E
    Neurochem Res; 1996 Aug; 21(8):897-901. PubMed ID: 8895842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity.
    Berkenbosch F; Tilders FJ
    Brain Res; 1988 Mar; 442(2):312-20. PubMed ID: 2453250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of endogenous opioids in the inhibition of luteinizing hormone by corticotropin-releasing factor.
    Almeida OF; Nikolarakis KE; Herz A
    Endocrinology; 1988 Mar; 122(3):1034-41. PubMed ID: 3257730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin-releasing factor decreases plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophysial-portal circulation.
    Petraglia F; Sutton S; Vale W; Plotsky P
    Endocrinology; 1987 Mar; 120(3):1083-8. PubMed ID: 3542513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of corticotropin-releasing factor receptor-2 in stress-induced suppression of pulsatile luteinizing hormone secretion in the rat.
    Li XF; Bowe JE; Lightman SL; O'Byrne KT
    Endocrinology; 2005 Jan; 146(1):318-22. PubMed ID: 15388651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CRF in the median eminence on gonadotropin levels in conscious female rats.
    Frias J; Ruiz E; Rodriguez E; Ortega E
    Neurochem Int; 1990; 17(4):605-8. PubMed ID: 20504664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of corticotropin-releasing factor on reproductive functions in the rat.
    Rivier C; Vale W
    Endocrinology; 1984 Mar; 114(3):914-21. PubMed ID: 6321146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH release from the mediobasal hypothalamus: in vitro inhibition by corticotropin-releasing factor.
    Gambacciani M; Yen SS; Rasmussen DD
    Neuroendocrinology; 1986; 43(4):533-6. PubMed ID: 3018610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor induces differential behavioral and cardiovascular effects after intracerebroventricular and lateral hypothalamic/perifornical injections in rats.
    Diamant M; Kashtanov SI; Fodor M; de Wied D
    Neuroendocrinology; 1992 Nov; 56(5):750-60. PubMed ID: 1488107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of naloxone in the median eminence on gonadotrophin secretion in intact male rats.
    Ruiz E; Osorio E; Ortega E
    Biochem Mol Biol Int; 1993 Dec; 31(5):889-95. PubMed ID: 8136706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Endorphin modulates the inhibitory action of corticotropin-releasing factor on luteinizing hormone secretion.
    Petraglia F; Vale W; Rivier C
    NIDA Res Monogr; 1986; 75():331-4. PubMed ID: 2893271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
    Rivest S; Plotsky PM; Rivier C
    Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular monoamines and their metabolites in the mediobasal hypothalamus--median eminence of anestrous and estrous ewes during CRF treatment.
    Tomaszewska D; Mateusiak K; Przekop F
    Exp Clin Endocrinol Diabetes; 1997; 105(3):175-81. PubMed ID: 9228515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of hyperprolactinemia on the control of luteinizing hormone and follicle-stimulating hormone secretion in the male rat.
    Smith MS; Bartke A
    Biol Reprod; 1987 Feb; 36(1):138-47. PubMed ID: 3105612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF.
    Bruhn TO; Plotsky PM; Vale WW
    Endocrinology; 1984 Jan; 114(1):57-62. PubMed ID: 6317350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.